Edwards Lifesciences Completes Acquisitions of JenaValve Technology and Endotronix
07/25/24, 11:09 AM
Location
irvineirvinenapervilleIndustry
medical device
artificial intelligence
biotechnology
health care
medical device
biotechnology
health care
manufacturing
healthcare
Edwards Lifesciences today announced investments that reflect the company’s deep commitment to advancing patient care through structural heart innovation. The company has entered into an agreement to acquire JenaValve Technology, a pioneer in the transcatheter treatment of aortic regurgitation and has exercised its option to acquire Endotronix, a leader in heart failure management solutions.
Company Info
Location
Irvine, California, United States
Company info
The Critical Care product group from Edwards Lifesciences is a global leader in advanced monitoring solutions, AI-enabled clinical decision tools, and innovative healthcare technologies. It has a strong presence in Irvine, Calif., and offers a portfolio of smart technologies that contribute to improving patient care and clinical decision support tools.
Related People
Unlock Verified Contacts + AI Outreach
Instantly access verified contact emails — and let Fundz AI draft a hyper-personalized message based on their role, company, and your company's offering.
Bh
Bh • Executive
Email hidden • Upgrade to unlock
Trusted by teams at Google, Oracle, HubSpot & more
Unlock Verified Contacts + AI Outreach
Instantly access verified contact emails — and let Fundz AI draft a hyper-personalized message based on their role, company, and your company's offering.
Th
Th • Executive
Email hidden • Upgrade to unlock
Trusted by teams at Google, Oracle, HubSpot & more